Published in Infect Immun on November 10, 2008
Ehrlichia chaffeensis TRP120 binds a G+C-rich motif in host cell DNA and exhibits eukaryotic transcriptional activator function. Infect Immun (2011) 0.92
Natural killer cells promote tissue injury and systemic inflammatory responses during fatal Ehrlichia-induced toxic shock-like syndrome. Am J Pathol (2010) 0.92
Ehrlichia chaffeensis induces monocyte inflammatory responses through MyD88, ERK, and NF-κB but not through TRIF, interleukin-1 receptor 1 (IL-1R1)/IL-18R1, or toll-like receptors. Infect Immun (2011) 0.89
TLR2 and Nod2 mediate resistance or susceptibility to fatal intracellular Ehrlichia infection in murine models of ehrlichiosis. PLoS One (2013) 0.85
Progress and obstacles in vaccine development for the ehrlichioses. Expert Rev Vaccines (2010) 0.84
Cyclic dimeric GMP signaling regulates intracellular aggregation, sessility, and growth of Ehrlichia chaffeensis. Infect Immun (2011) 0.80
Understanding Anaplasmataceae pathogenesis using "Omics" approaches. Front Cell Infect Microbiol (2014) 0.80
Penicillin-binding protein of Ehrlichia chaffeensis: cytokine induction through MyD88-dependent pathway. J Infect Dis (2012) 0.78
Tick-Pathogen Ensembles: Do Molecular Interactions Lead Ecological Innovation? Front Cell Infect Microbiol (2017) 0.76
Ehrlichia secretes Etf-1 to induce autophagy and capture nutrients for its growth through RAB5 and class III phosphatidylinositol 3-kinase. Autophagy (2016) 0.75
Autoimmune disease triggered by infection with alphaproteobacteria. Expert Rev Clin Immunol (2009) 0.75
Innate immune recognition. Annu Rev Immunol (2001) 26.65
The many roles of chemokines and chemokine receptors in inflammation. N Engl J Med (2006) 10.99
The biology of chemokines and their receptors. Annu Rev Immunol (2000) 9.81
Lipocalin 2 mediates an innate immune response to bacterial infection by sequestrating iron. Nature (2004) 9.40
Abnormalities in monocyte recruitment and cytokine expression in monocyte chemoattractant protein 1-deficient mice. J Exp Med (1998) 6.52
Human infection with Ehrlichia canis, a leukocytic rickettsia. N Engl J Med (1987) 6.06
Isolation and characterization of an Ehrlichia sp. from a patient diagnosed with human ehrlichiosis. J Clin Microbiol (1991) 6.00
Neutrophil and B cell expansion in mice that lack the murine IL-8 receptor homolog. Science (1994) 5.20
IL-13 signaling through the IL-13alpha2 receptor is involved in induction of TGF-beta1 production and fibrosis. Nat Med (2005) 5.13
Chemokines in innate and adaptive host defense: basic chemokinese grammar for immune cells. Annu Rev Immunol (2004) 5.07
The SCID mouse mutant: definition, characterization, and potential uses. Annu Rev Immunol (1991) 3.95
RANTES deposition by platelets triggers monocyte arrest on inflamed and atherosclerotic endothelium. Circulation (2001) 3.86
Interleukin-1 type II receptor: a decoy target for IL-1 that is regulated by IL-4. Science (1993) 3.62
Ehrlichia chaffeensis: a prototypical emerging pathogen. Clin Microbiol Rev (2003) 3.39
IP-10 is critical for effector T cell trafficking and host survival in Toxoplasma gondii infection. Immunity (2000) 2.58
Lipopolysaccharides in liver injury: molecular mechanisms of Kupffer cell activation. Am J Physiol Gastrointest Liver Physiol (2002) 2.46
Genomic characterization of a gamma-interferon-inducible gene (IP-10) and identification of an interferon-inducible hypersensitive site. Mol Cell Biol (1987) 2.41
The human ehrlichioses in the United States. Emerg Infect Dis (1999) 2.22
Cloning of a type I cytokine receptor most related to the IL-2 receptor beta chain. Proc Natl Acad Sci U S A (2000) 2.16
Hijacking and exploitation of IL-10 by intracellular pathogens. Trends Microbiol (2001) 2.03
Acute phase reaction and acute phase proteins. J Zhejiang Univ Sci B (2005) 2.03
Role of cytokines in cardiovascular diseases: a focus on endothelial responses to inflammation. Clin Sci (Lond) (2005) 1.85
Alpha(1)-acid glycoprotein: an acute phase protein with inflammatory and immunomodulating properties. Cytokine Growth Factor Rev (2003) 1.72
Intracellular infection by the human granulocytic ehrlichiosis agent inhibits human neutrophil apoptosis. Infect Immun (2000) 1.69
Abrogation of gamma interferon-induced inhibition of Ehrlichia chaffeensis infection in human monocytes with iron-transferrin. Infect Immun (1994) 1.68
Role of interleukin 6 in myocardial dysfunction of meningococcal septic shock. Lancet (2004) 1.56
Transforming growth factor-beta: innately bipolar. Curr Opin Immunol (2006) 1.52
Lymphoid organ development and cell migration. Immunol Rev (2003) 1.42
Expression patterns of IL-10 ligand and receptor gene families provide leads for biological characterization. Int Immunopharmacol (2004) 1.38
Endothelial activation: intracellular signaling pathways. Arthritis Res (2002) 1.36
The function of antigen-presenting cells in mice with severe combined immunodeficiency. J Immunol (1985) 1.36
Survival strategy of obligately intracellular Ehrlichia chaffeensis: novel modulation of immune response and host cell cycles. Infect Immun (2004) 1.34
CD137 is expressed on blood vessel walls at sites of inflammation and enhances monocyte migratory activity. FASEB J (2006) 1.34
Human endothelium as a source of multifunctional cytokines: molecular regulation and possible role in human disease. J Interferon Cytokine Res (1999) 1.33
Transcriptional profiling of host responses in mouse lungs following aerosol infection with type A Francisella tularensis. J Med Microbiol (2006) 1.29
Chemokines: role in inflammation and immune surveillance. Ann Rheum Dis (2004) 1.28
A role for BLyS in the activation of innate immune cells. Blood (2006) 1.27
Infection of the laboratory mouse with the intracellular pathogen Ehrlichia chaffeensis. Infect Immun (1998) 1.23
Critical role of toll-like receptors and the common TLR adaptor, MyD88, in induction of granulomas and liver injury. J Hepatol (2006) 1.22
Defects in the oxidative killing of microorganisms by phagocytic leukocytes. Ciba Found Symp (1979) 1.20
Structure, chromosome localization, and regulation of expression of the interferon-regulated mouse Ifi54/Ifi56 gene family. Genomics (1994) 1.19
Neutrophil CD64 is a sensitive diagnostic marker for early-onset neonatal infection. Pediatr Res (2004) 1.17
Distinct gene expression profiles characterize the histopathological stages of disease in Helicobacter-induced mucosa-associated lymphoid tissue lymphoma. Proc Natl Acad Sci U S A (2003) 1.16
Acute endotoxemia is associated with upregulation of lipocalin 24p3/Lcn2 in lung and liver. Exp Mol Pathol (2007) 1.14
Protective immunity against Helicobacter is characterized by a unique transcriptional signature. Proc Natl Acad Sci U S A (2003) 1.10
Molecular heterogeneity of Ehrlichia chaffeensis isolates determined by sequence analysis of the 28-kilodalton outer membrane protein genes and other regions of the genome. Infect Immun (2003) 1.09
Myeloperoxidase in human lung lavage. I. A marker of local neutrophil activity. Inflammation (1990) 1.09
Hepatic pathology in human monocytic ehrlichiosis. Ehrlichia chaffeensis infection. Am J Clin Pathol (2003) 1.06
Polymers and inflammation: disease mechanisms of the serpinopathies. J Exp Med (2008) 1.06
Induction of the human gene for p44, a hepatitis-C-associated microtubular aggregate protein, by interferon-alpha/beta. Eur J Biochem (1994) 1.05
Two adjacent C/EBP-binding sequences that participate in the cell-specific expression of the mouse serum amyloid A3 gene. Mol Cell Biol (1990) 1.04
ILA, a member of the human nerve growth factor/tumor necrosis factor receptor family, regulates T-lymphocyte proliferation and survival. Blood (1996) 1.02
Virulence potential of Ehrlichia chaffeensis strains of distinct genome sequences. Infect Immun (2007) 1.02
Regulated expression and release of the IL-1 decoy receptor in human mononuclear phagocytes. J Immunol (1996) 1.00
C-reactive protein and alpha 1-acid glycoprotein levels in dogs infected with Ehrlichia canis. J Clin Microbiol (1994) 1.00
Expression and function of CD7 molecule on human natural killer cells. J Immunol (1994) 0.96
Differential and additive effects of platelet-derived chemokines on monocyte arrest on inflamed endothelium under flow conditions. J Leukoc Biol (2005) 0.95
A non-invasive quantitative assay to measure murine intestinal inflammation using the neutrophil marker lactoferrin. J Immunol Methods (2006) 0.93
Molecular cloning and characterization of a novel liver-specific transport protein. J Cell Sci (1994) 0.93
Interleukin-21 stimulates antigen uptake, protease activity, survival and induction of CD4+ T cell proliferation by murine macrophages. Clin Exp Immunol (2008) 0.91
Analysis of a 1-Mb BAC contig overlapping the mouse Nkrp1 cluster of genes: cloning of three new Nkrp1 members, Nkrp1d, Nkrp1e, and Nkrp1f. Immunogenetics (2001) 0.89
Expression of neutrophil activation markers and neutrophil adhesion to chondrocytes in rheumatoid arthritis patients: relationship with disease activity. Res Immunol (1995) 0.86
Transcriptional activation of CYP2C, MxA and Fas in sudden infant death syndrome. Int J Mol Med (1999) 0.76
Comparative genomics of emerging human ehrlichiosis agents. PLoS Genet (2006) 4.23
Ehrlichia chaffeensis and Anaplasma phagocytophilum lack genes for lipid A biosynthesis and incorporate cholesterol for their survival. Infect Immun (2003) 2.37
Ultrastructure and phylogenetic analysis of 'Candidatus Neoehrlichia mikurensis' in the family Anaplasmataceae, isolated from wild rats and found in Ixodes ovatus ticks. Int J Syst Evol Microbiol (2004) 2.35
Anaplasma phagocytophilum AnkA secreted by type IV secretion system is tyrosine phosphorylated by Abl-1 to facilitate infection. Cell Microbiol (2007) 2.09
Characterization and transcriptional analysis of gene clusters for a type IV secretion machinery in human granulocytic and monocytic ehrlichiosis agents. Infect Immun (2002) 1.61
Revision of haemotrophic Mycoplasma species names. Int J Syst Evol Microbiol (2002) 1.57
Analysis of sequences and loci of p44 homologs expressed by Anaplasma phagocytophila in acutely infected patients. J Clin Microbiol (2002) 1.45
Human infection with Ehrlichia canis accompanied by clinical signs in Venezuela. Ann N Y Acad Sci (2006) 1.43
Transcript heterogeneity of the p44 multigene family in a human granulocytic ehrlichiosis agent transmitted by ticks. Infect Immun (2002) 1.43
Novel genetic variants of Anaplasma phagocytophilum, Anaplasma bovis, Anaplasma centrale, and a novel Ehrlichia sp. in wild deer and ticks on two major islands in Japan. Appl Environ Microbiol (2006) 1.31
Autophagosomes induced by a bacterial Beclin 1 binding protein facilitate obligatory intracellular infection. Proc Natl Acad Sci U S A (2012) 1.28
Mechanisms of variable p44 expression by Anaplasma phagocytophilum. Infect Immun (2003) 1.28
Surface-exposed proteins of Ehrlichia chaffeensis. Infect Immun (2007) 1.26
Transstadial and intrastadial experimental transmission of Ehrlichia canis by male Rhipicephalus sanguineus. Vet Parasitol (2005) 1.24
Anaplasma phagocytophilum Ats-1 is imported into host cell mitochondria and interferes with apoptosis induction. PLoS Pathog (2010) 1.23
Sequence analysis of p44 homologs expressed by Anaplasma phagocytophilum in infected ticks feeding on naive hosts and in mice infected by tick attachment. Infect Immun (2004) 1.22
Subversion of cellular autophagy by Anaplasma phagocytophilum. Cell Microbiol (2007) 1.22
The omp-1 major outer membrane multigene family of Ehrlichia chaffeensis is differentially expressed in canine and tick hosts. Infect Immun (2002) 1.21
Rapid sequential changeover of expressed p44 genes during the acute phase of Anaplasma phagocytophilum infection in horses. Infect Immun (2004) 1.21
Neorickettsia risticii is vertically transmitted in the trematode Acanthatrium oregonense and horizontally transmitted to bats. Environ Microbiol (2005) 1.19
Global proteomic analysis of two tick-borne emerging zoonotic agents: anaplasma phagocytophilum and ehrlichia chaffeensis. Front Microbiol (2011) 1.18
Anaplasma phagocytophilum inhibits human neutrophil apoptosis via upregulation of bfl-1, maintenance of mitochondrial membrane potential and prevention of caspase 3 activation. Cell Microbiol (2005) 1.18
Intra-leukocyte expression of two-component systems in Ehrlichia chaffeensis and Anaplasma phagocytophilum and effects of the histidine kinase inhibitor closantel. Cell Microbiol (2006) 1.18
Differential expression of VirB9 and VirB6 during the life cycle of Anaplasma phagocytophilum in human leucocytes is associated with differential binding and avoidance of lysosome pathway. Cell Microbiol (2006) 1.17
Detection of Ehrlichia canis in canine carrier blood and in individual experimentally infected ticks with a p30-based PCR assay. J Clin Microbiol (2002) 1.16
Effects of Anaplasma phagocytophila on NADPH oxidase components in human neutrophils and HL-60 cells. Infect Immun (2002) 1.16
Obligatory intracellular parasitism by Ehrlichia chaffeensis and Anaplasma phagocytophilum involves caveolae and glycosylphosphatidylinositol-anchored proteins. Cell Microbiol (2003) 1.15
Identification of novel surface proteins of Anaplasma phagocytophilum by affinity purification and proteomics. J Bacteriol (2007) 1.13
Cyclic di-GMP signaling regulates invasion by Ehrlichia chaffeensis of human monocytes. J Bacteriol (2010) 1.13
Establishment of cloned Anaplasma phagocytophilum and analysis of p44 gene conversion within an infected horse and infected SCID mice. Infect Immun (2005) 1.12
Anaplasma phagocytophilum delays spontaneous human neutrophil apoptosis by modulation of multiple apoptotic pathways. Cell Microbiol (2006) 1.12
Biochemical activities of three pairs of Ehrlichia chaffeensis two-component regulatory system proteins involved in inhibition of lysosomal fusion. Infect Immun (2006) 1.12
The Anaplasma phagocytophilum PleC histidine kinase and PleD diguanylate cyclase two-component system and role of cyclic Di-GMP in host cell infection. J Bacteriol (2008) 1.09
Porin activity of Anaplasma phagocytophilum outer membrane fraction and purified P44. J Bacteriol (2006) 1.08
Regulation of type IV secretion apparatus genes during Ehrlichia chaffeensis intracellular development by a previously unidentified protein. J Bacteriol (2008) 1.08
Proteomic analysis of and immune responses to Ehrlichia chaffeensis lipoproteins. Infect Immun (2008) 1.07
Ehrlichia chaffeensis downregulates surface Toll-like receptors 2/4, CD14 and transcription factors PU.1 and inhibits lipopolysaccharide activation of NF-kappa B, ERK 1/2 and p38 MAPK in host monocytes. Cell Microbiol (2004) 1.06
Rapid activation of protein tyrosine kinase and phospholipase C-gamma2 and increase in cytosolic free calcium are required by Ehrlichia chaffeensis for internalization and growth in THP-1 cells. Infect Immun (2002) 1.06
Virulence potential of Ehrlichia chaffeensis strains of distinct genome sequences. Infect Immun (2007) 1.02
Tick acquisition of Ehrlichia canis from dogs treated with doxycycline hyclate. Antimicrob Agents Chemother (2007) 1.02
Insights into the CtrA regulon in development of stress resistance in obligatory intracellular pathogen Ehrlichia chaffeensis. Mol Microbiol (2011) 1.01
Two monoclonal antibodies with defined epitopes of P44 major surface proteins neutralize Anaplasma phagocytophilum by distinct mechanisms. Infect Immun (2006) 1.01
Anaplasma phagocytophilum p44 mRNA expression is differentially regulated in mammalian and tick host cells: involvement of the DNA binding protein ApxR. J Bacteriol (2007) 1.00
Expression and porin activity of P28 and OMP-1F during intracellular Ehrlichia chaffeensis development. J Bacteriol (2008) 1.00
Analysis of involvement of the RecF pathway in p44 recombination in Anaplasma phagocytophilum and in Escherichia coli by using a plasmid carrying the p44 expression and p44 donor loci. Infect Immun (2006) 1.00
Analysis of complete genome sequence of Neorickettsia risticii: causative agent of Potomac horse fever. Nucleic Acids Res (2009) 0.99
Ehrlichia ewingii infection delays spontaneous neutrophil apoptosis through stabilization of mitochondria. J Infect Dis (2008) 0.96
Experimental infection of dairy calves with Ehrlichia chaffeensis. J Med Microbiol (2007) 0.95
Proteomic identification of a novel Anaplasma phagocytophilum DNA binding protein that regulates a putative transcription factor. J Bacteriol (2007) 0.95
Polymorphism and transcription at the p44-1/p44-18 genomic locus in Anaplasma phagocytophilum strains from diverse geographic regions. Infect Immun (2004) 0.95
Activation of a p44 pseudogene in Anaplasma phagocytophila by bacterial RNA splicing: a novel mechanism for post-transcriptional regulation of a multigene family encoding immunodominant major outer membrane proteins. Mol Microbiol (2002) 0.95
Anaplasma phagocytophilum has a functional msp2 gene that is distinct from p44. Infect Immun (2004) 0.95
Cholesterol-dependent anaplasma phagocytophilum exploits the low-density lipoprotein uptake pathway. PLoS Pathog (2009) 0.94
Four VirB6 paralogs and VirB9 are expressed and interact in Ehrlichia chaffeensis-containing vacuoles. J Bacteriol (2008) 0.94
Sequence and expression analysis of virB9 of the type IV secretion system of Ehrlichia canis strains in ticks, dogs, and cultured cells. Infect Immun (2003) 0.93
Cytokine gene expression by peripheral blood leukocytes in horses experimentally infected with Anaplasma phagocytophila. Clin Diagn Lab Immunol (2002) 0.92
Degradation of p22phox and inhibition of superoxide generation by Ehrlichia chaffeensis in human monocytes. Cell Microbiol (2006) 0.92
Cytokine gene expression by peripheral blood leukocytes in dogs experimentally infected with a new virulent strain of Ehrlichia canis. Ann N Y Acad Sci (2006) 0.91
Molecular analysis of Neorickettsia risticii in adult aquatic insects in Pennsylvania, in horses infected by ingestion of insects, and isolated in cell culture. J Clin Microbiol (2002) 0.91
Reinfection with Ehrlichia chaffeensis in a liver transplant recipient. Clin Infect Dis (2002) 0.90
Molecular link of different stages of the trematode host of Neorickettsia risticii to Acanthatrium oregonense. Environ Microbiol (2008) 0.89
Ehrlichia chaffeensis induces monocyte inflammatory responses through MyD88, ERK, and NF-κB but not through TRIF, interleukin-1 receptor 1 (IL-1R1)/IL-18R1, or toll-like receptors. Infect Immun (2011) 0.89
Subversion of host cell signaling by Orientia tsutsugamushi. Microbes Infect (2011) 0.88
High-cholesterol diet facilitates Anaplasma phagocytophilum infection and up-regulates macrophage inflammatory protein-2 and CXCR2 expression in apolipoprotein E-deficient mice. J Infect Dis (2007) 0.87
Ehrlichia type IV secretion effector ECH0825 is translocated to mitochondria and curbs ROS and apoptosis by upregulating host MnSOD. Cell Microbiol (2012) 0.87
Ats-1: a novel bacterial molecule that links autophagy to bacterial nutrition. Autophagy (2013) 0.87
Transcriptional analysis of p30 major outer membrane protein genes of Ehrlichia canis in naturally infected ticks and sequence analysis of p30-10 of E canis from diverse geographic regions. J Clin Microbiol (2003) 0.85
Subversion of NPC1 pathway of cholesterol transport by Anaplasma phagocytophilum. Cell Microbiol (2012) 0.85
Borrelia burgdorferi oxidative stress regulator BosR directly represses lipoproteins primarily expressed in the tick during mammalian infection. Mol Microbiol (2013) 0.85
Ehrlichia chaffeensis infection of sika deer, Japan. Emerg Infect Dis (2009) 0.84
The prenylation inhibitor manumycin A reduces the viability of Anaplasma phagocytophilum. J Med Microbiol (2011) 0.83
Optimization of proteomic sample preparation procedures for comprehensive protein characterization of pathogenic systems. J Biomol Tech (2008) 0.81
Development of a p28-based PCR assay for Ehrlichia chaffeensis. Mol Cell Probes (2004) 0.81
Ehrlichia chaffeensis uses its surface protein EtpE to bind GPI-anchored protein DNase X and trigger entry into mammalian cells. PLoS Pathog (2013) 0.81
Evaluation of peptide- and recombinant protein-based assays for detection of anti-Ehrlichia ewingii antibodies in experimentally and naturally infected dogs. [corrected] Am J Vet Res (2010) 0.80
Cyclic dimeric GMP signaling regulates intracellular aggregation, sessility, and growth of Ehrlichia chaffeensis. Infect Immun (2011) 0.80
Molecular detection and characterization of Ehrlichia canis from dogs in Turkey. Berl Munch Tierarztl Wochenschr (2005) 0.80
Antibiotic clearance of Ehrlichia canis from dogs infected by intravenous inoculation of carrier blood. Ann N Y Acad Sci (2008) 0.80
Identification of 19 polymorphic major outer membrane protein genes and their immunogenic peptides in Ehrlichia ewingii for use in a serodiagnostic assay. Clin Vaccine Immunol (2007) 0.79
Neorickettsia risticii surface-exposed proteins: proteomics identification, recognition by naturally-infected horses, and strain variations. Vet Res (2011) 0.79
Cytokine responses in dogs infected with Ehrlichia canis Oklahoma strain. Ann N Y Acad Sci (2005) 0.79
Proteomic analysis of Neorickettsia sennetsu surface-exposed proteins and porin activity of the major surface protein P51. J Bacteriol (2010) 0.79
Penicillin-binding protein of Ehrlichia chaffeensis: cytokine induction through MyD88-dependent pathway. J Infect Dis (2012) 0.78
Pathologic evidence of ehrlichiosis in calves inoculated with Ehrlichia chaffeensis. Ann N Y Acad Sci (2008) 0.77
Evaluation of sensitivity and specificity of a Mycoplasma haemomuris-specific polymerase chain reaction test. Comp Med (2002) 0.76
Cloning of the major outer membrane protein expression locus in Anaplasma platys and seroreactivity of a species-specific antigen. J Bacteriol (2011) 0.76
Investigating interference with apoptosis induction by bacterial proteins. Methods Mol Biol (2014) 0.76
Proposal to transfer 'Aegyptianella ranarum', an intracellular bacterium of frog red blood cells, to the family Flavobacteriaceae as 'Candidatus Hemobacterium ranarum' comb. nov. Environ Microbiol (2004) 0.75
Diagnosis of Ehrlichia ewingii infection by PCR in a puppy from Ohio. Vet Clin Pathol (2009) 0.75
Diagnosis of canine monocytic ehrlichiosis: development of advanced techniques to combat a global disease. Vet J (2010) 0.75
Characteristics of the 16S-23S rRNA intergenic spacer region of Mycoplasma haemomuris, previously classified as 'Haemobartonella muris'. J Vet Med Sci (2002) 0.75